Vertex Pharmaceuticals Incorporated
Hedge Funds Holdings
Last updated:
Vertex Pharmaceuticals Incorporated‘s stocks are currently a part of 1033 hedge funds’ portfolios, which represents 88.99% of the total amount of its stocks outstanding. This makes up a total of 231.29M shares of Vertex Pharmaceuticals Incorporated. Compared to the previous quarter, the number grew by 0.85% or 1.94M shares more. As for the holding position changes, 38.63% (399) of current hedge fund investors increased the number of shares held, 35.04% (362) of current holders sold a part of the shares held, and 10.07% (104) closed the holdings completely. 148 hedge funds are new holders of Vertex Pharmaceuticals Incorporated stock in Q1 2022, it is 14.33% of total holders.
Hedge funds holding Vertex Pharmaceuticals Incorporated (Q2 2017 – Q1 2022)
| Q2 2017 | 574 |
|---|---|
| Q3 2017 | 605 |
| Q4 2017 | 637 |
| Q1 2018 | 672 |
| Q2 2018 | 682 |
| Q3 2018 | 689 |
| Q4 2018 | 697 |
| Q1 2019 | 728 |
| Q2 2019 | 705 |
| Q3 2019 | 697 |
| Q4 2019 | 799 |
| Q1 2020 | 838 |
| Q2 2020 | 938 |
| Q3 2020 | 926 |
| Q4 2020 | 942 |
| Q1 2021 | 972 |
| Q2 2021 | 951 |
| Q3 2021 | 911 |
| Q4 2021 | 1,008 |
| Q1 2022 | 1,033 |
Hedge funds changes in Vertex Pharmaceuticals Incorporated positions (Q2 2017 – Q1 2022)
| Q2 2017 | 105 | 213 | 182 | 37 | 37 |
|---|---|---|---|---|---|
| Q3 2017 | 81 | 267 | 180 | 40 | 37 |
| Q4 2017 | 101 | 257 | 202 | 63 | 14 |
| Q1 2018 | 97 | 241 | 238 | 57 | 39 |
| Q2 2018 | 65 | 274 | 239 | 53 | 51 |
| Q3 2018 | 78 | 250 | 242 | 64 | 55 |
| Q4 2018 | 93 | 234 | 262 | 82 | 26 |
| Q1 2019 | 95 | 292 | 224 | 62 | 55 |
| Q2 2019 | 73 | 276 | 242 | 86 | 28 |
| Q3 2019 | 63 | 287 | 234 | 71 | 42 |
| Q4 2019 | 160 | 273 | 265 | 42 | 59 |
| Q1 2020 | 130 | 324 | 274 | 84 | 26 |
| Q2 2020 | 167 | 396 | 266 | 60 | 49 |
| Q3 2020 | 91 | 396 | 316 | 94 | 29 |
| Q4 2020 | 155 | 374 | 310 | 131 | -28 |
| Q1 2021 | 140 | 416 | 304 | 105 | 7 |
| Q2 2021 | 113 | 387 | 328 | 124 | -1 |
| Q3 2021 | 97 | 355 | 338 | 131 | -10 |
| Q4 2021 | 195 | 334 | 357 | 89 | 33 |
| Q1 2022 | 148 | 399 | 362 | 104 | 20 |
Hedge funds changes in Vertex Pharmaceuticals Incorporated stock options (Q2 2017 – Q1 2022)
| Q2 2017 | 416,218,000 | 169,380,000 |
|---|---|---|
| Q3 2017 | 385,512,000 | 331,291,000 |
| Q4 2017 | 205,661,000 | 225,067,726 |
| Q1 2018 | 216,426,198 | 219,725,416 |
| Q2 2018 | 293,784,796 | 305,604,264 |
| Q3 2018 | 402,876,514 | 351,979,340 |
| Q4 2018 | 402,759,321 | 407,172,135 |
| Q1 2019 | 303,276,135 | 243,945,930 |
| Q2 2019 | 308,780,828 | 276,681,958 |
| Q3 2019 | 252,671,852 | 301,564,522 |
| Q4 2019 | 368,886,620 | 388,180,445 |
| Q1 2020 | 17,306,386,000 | 12,263,960,950 |
| Q2 2020 | 47,325,497,085 | 2,323,935,310 |
| Q3 2020 | 267,409,060 | 288,405,448 |
| Q4 2020 | 276,341,876 | 370,299,236 |
| Q1 2021 | 638,600,375 | 19,565,702,657,670 |
| Q2 2021 | 721,842,125 | 5,265,707,927,890 |
| Q3 2021 | 469,577,125 | 527,157,170 |
| Q4 2021 | 652,015,160 | 547,131,560 |
| Q1 2022 | 590,314,000 | 863,070,000 |